Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen.

Trial Profile

Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Eptifibatide (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Acronyms CLEAR-FDR
  • Most Recent Events

    • 19 Feb 2016 Results of pooled analysis (n=247) of this and other 2 trials (CLEAR and CLEAR-ER) presented at the 41st International Stroke Conference
    • 27 May 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 08 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top